Atlas Trials

Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney

Clinical trial NCT00853021 · COMPLETED

Trial details

NCT number
NCT00853021
Sponsor
Jorge A. Garcia, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Cancer
Start date
2005-12-01
Primary completion
2009-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.